Navegar por término CIE "Leucemia mieloide aguda"

Mostrando ítems 1-5 de 5

A prognostic model for survival after salvage treatment with FLAG-Ida +/- gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia

2016- Bergua, Juan; Montesinos, Pau; Martínez-Cuadrón, David; Fernández-Abellán, Pascual; Serrano, Josefina; [et al.]
Autologous or Allogeneic Hematopoietic Stem Cell Transplantation as Front-Line Treatment for Adult Secondary Acute Myeloid Leukemia Patients: The PETHEMA Registry Experience

2025-05- Serrano, Josefina; Martínez-Cuadrón, David; Gil, Cristina; Bernal, Teresa; Tormo, Mar; [et al.]
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?

2021-06- Martínez-Cuadrón, David; Serrano, Josefina; Gil, Cristina; Tormo, Mar; Martínez-Sánchez, Pilar; [et al.]
FLT3 inhibitors in the treatment of acute myeloid leukemia: current status and future perspectives

2020-10- Mosquera Orgueira, Adrián; Bao Pérez, Laura; Mosquera Torre, Alicia; Peleteiro Raindo, Andrés; Cid López, Miguel; [et al.]
Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry

2025-11- Alfonso Pierola, Ana; Martínez-Cuadrón, David; Rodríguez-Veiga, Rebeca; Gil, Cristina; Martínez-Sánchez, Pilar; [et al.]